Blood-based transcriptomics: Leukemias and beyond

Expert Review of Molecular Diagnostics

Volumn 9, Issue 3, 2009, Pages 271-280

  Staratschek Jox, Andrea ^a   Classen, Sabine ^a   Gaarz, Andrea ^a   Debey Pascher, Svenja ^a   Schultze, Joachim L ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Blood; DNA; Gene expression; Inflammation; Leukemia; Microarray; Molecular diagnostics; Molecular profiling; Transcriptomics

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; CANCER CLASSIFICATION; CANCER GROWTH; CHRONIC LEUKEMIA; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION PROFILING; HUMAN; LEUKEMIA; MICROARRAY ANALYSIS; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

AUTOIMMUNE DISEASES; BLOOD; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 66749102675     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.09.9     Document Type: Review

References (57)

1. Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286(5439), 531-537 (1999).
2. Hedenfalk I, Duggan D, Chen Y et al. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344(8), 539-548 (2001).
3. Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98(19), 10869-10874 (2001).
4. Bhattacharjee A, Richards WG, Staunton J et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl Acad. Sci. USA 98(24), 13790-13795 (2001).
5. Takahashi M, Yang XJ, Sugimura J et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 2(43), 6810-6818 (2003).
6. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769), 503-511 (2000).
7. Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346(25), 1937-1947 (2002).
8. Bittner M, Meltzer P, Chen Y et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406(6795), 536-540 (2000).
9. Shipp MA, Ross KN, Tamayo P et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8(1), 68-74 (2002).
10. Ramilo O, Allman W, Chung W et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109(5), 2066-2077 (2007).
11. Boldrick JC, Alizadeh AA, Diehn M et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc. Natl Acad. Sci. USA 99(2), 972-977 (2002).
12. Chaussabel D, Allman W, Mejias A et al. Analysis of significance patterns identifies ubiquitous and disease-specific gene- expression signatures in patient peripheral blood leukocytes. Ann. NY Acad. Sci. 1062, 146-154 (2005).
13. Kittleson MM, Ye SQ, Irizarry RA et al. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation 110(22), 3444-3451 (2004).
14. Horwitz PA, Tsai EJ, Putt ME et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 110(25), 3815-3821 (2004).
15. Olsen N, Sokka T, Seehorn CL et al. A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann. Rheum. Dis. 63(11), 1387-1392 (2004).
16. Chaussabel D, Quinn C, Shen J et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29(1), 150-164 (2008).
17. Liu Z, Yelverton RW, Kraft B, Tanner SB, Olsen NJ, Aune TM. Highly conserved gene expression profiles in humans with allergic rhinitis altered by immunotherapy. Clin. Exp. Allergy 35(12), 1581-1590 (2005).
18. Thuerigen O, Schneeweiss A, Toedt G et al. Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. J. Clin. Oncol. 24(12), 1839-1845 (2006).
19. van 't Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871), 530-536 (2002).
20. Hakonarson H, Bjornsdottir US, Halapi E et al. Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc. Natl Acad. Sci. USA 102(41), 14789-14794 (2005).
21. Haferlach T, Kohlmann A, Schnittger S et al. Global approach to the diagnosis of leukemia using gene expression profiling. Blood 106(4), 1189-1198 (2005).
22. Valk PJ, Verhaak RG, Beijen MA et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Engl. J. Med. 350(16), 1617-1628 (2004).
23. Schoch C, Kohlmann A, Schnittger S et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc. Natl Acad. Sci. USA 99(15), 10008-10013 (2002).
24. Larkin JE, Frank BC, Gavras H, Sultana R, Quackenbush J. Independence and reproducibility across microarray platforms. Nat. Methods 2(5), 337-344 (2005).
25. Irizarry RA, Warren D, Spencer F et al. Multiple-laboratory comparison of microarray platforms. Nat. Methods 2(5), 345-350 (2005).
26. Bammler T, Beyer RP, Bhattacharya S et al. Standardizing global gene expression analysis between laboratories and across platforms. Nat. Methods 2(5), 351-356 (2005).
27. Debey S, Schoenbeck U, Hellmich M et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J. 4(3), 193-207 (2004).
28. Leiva IM, Emmert-Buck MR, Gillespie JW. Handling of clinical tissue specimens for molecular profiling studies. Curr. Issues Mol. Biol. 5(2), 27-35 (2003).
29. Brazma A, Hingamp P, Quackenbush J et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29(4), 365-371 (2001).
30. Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat. Rev. Genet. 7(1), 55-65 (2006).
31. Mullighan CG, Su X, Zhang J et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N. Engl. J. Med. 360(5), 470-480 (2009).
32. Debey S, Zander T, Brors B, Popov A, Eils R, Schultze JL. A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials. Genomics 87(5), 653-664 (2006).
33. Debey-Pascher S, Eggle D, Schultze JL. RNA stabilization of peripheral blood and profiling by bead chip analysis. Methods Mol. Biol. 496, 175-210 (2009).
34. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br. J. Haematol. 33(4), 451-458 (1976).
35. Jaffe ES, Harris NL, Diebold J, Muller- Hermelink HK. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am. J. Clin. Pathol. 111(Suppl. 1), S8-S12 (1999).
36. Bullinger L, Dohner K, Bair E et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med. 350(16), 1605-1616 (2004).
37. Falini B, Mecucci C, Tiacci E et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N. Engl. J. Med. 352(3), 254-266 (2005).
38. Verhaak RG, Goudswaard CS, van Putten W et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 106(12), 3747-3754 (2005).
39. Radmacher MD, Marcucci G, Ruppert AS et al. Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study. Blood 108(5), 1677-1683 (2006).
40. Wilson CS, Davidson GS, Martin SB et al. Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood 108(2), 685-696 (2006).
41. Metzeler KH, Hummel M, Bloomfield CD et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood 112(10), 4193-4201 (2008).
42. Yeoh EJ, Ross ME, Shurtleff SA et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1(2), 133-143 (2002).
43. Ross ME, Zhou X, Song G et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102(8), 2951-2959 (2003).
44. van Delft FW, Bellotti T, Luo Z et al. Prospective gene expression analysis accurately subtypes acute leukaemia in children and establishes a commonality between hyperdiploidy and t(12;21) in acute lymphoblastic leukaemia. Br. J. Haematol. 130(1), 26-35 (2005).
45. Andersson A, Ritz C, Lindgren D et al. Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia 21(6), 1198-1203 (2007).
46. Haslinger C, Schweifer N, Stilgenbauer S et al. Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. J. Clin. Oncol. 22(19), 3937-3949 (2004).
47. Wang E, Marincola FM. Bottom up: a modular view of immunology. Immunity 29(1), 9-11 (2008).
48. Mandel M, Achiron A. Gene expression studies in systemic lupus erythematosus. Lupus 15(7), 451-456 (2006).
49. Potti A, Bild A, Dressman HK, Lewis DA, Nevins JR, Ortel TL. Gene-expression patterns predict phenotypes of immune- mediated thrombosis. Blood 107(4), 1391-1396 (2006).
50. Fauci AS. The global challenge of infectious diseases: the evolving role of the National Institutes of Health in basic and clinical research. Nat. Immunol. 6(8), 743-747 (2005).
51. Jenner RG, Young RA. Insights into host responses against pathogens from transcriptional profiling. Nat. Rev. Microbiol. 3(4), 281-294 (2005).
52. Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173, 89-97 (2000).
53. Taylor MW, Tsukahara T, Brodsky L et al. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J. Virol. 81(7), 3391-3401 (2007).
54. Ockenhouse CF, Bernstein WB, Wang Z, Vahey MT. Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. J. Infect. Dis. 191(12), 2064-2074 (2005).
55. Ioannidis JP, Allison DB, Ball CA et al. Repeatability of published microarray gene expression analyses. Nat. Genet. 41(2), 149-155 (2009).
56. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365(9458), 488-492 (2005).
57. Hoffmann K, Firth MJ, Beesley AH, de Klerk NH, Kees UR. Translating microarray data for diagnostic testing in childhood leukaemia. BMC Cancer 6, 229 (2006).